Aragno, Elena
Fagiolini, Andrea
Cuomo, Alessandro
Paschetta, Elena
Maina, Giuseppe
Rosso, Gianluca https://orcid.org/0000-0002-2308-9146
Article History
Received: 11 October 2021
Accepted: 20 February 2022
First Online: 2 March 2022
Declarations
:
: Gianluca Rosso is/has been a speaker and/or consultant from Angelini, Janssen, Lundbeck, and Otsuka. Giuseppe Maina is/has been a consultant and/or a speaker and/or has received research grants from Angelini, Boheringer Ingelheim, FB-Health, Janssen, Lundbeck, Otsuka, and Innova Pharma. Cuomo Alessandro is/has been a consultant and/or a speaker and/or has received research grants from Angelini, Lundbeck, and Otsuka. Fagiolini Andrea is/has been a consultant and/or a speaker and/or has received research grants from Allergan, Angelini, Apsen, Boehringer Ingelheim, Doc Generici, FB‐Health, Janssen, Lundbeck, Mylan, Otsuka, Polifarma, Recordati, Sanofi Aventis, Sunovion, and Vifor. Elena Aragno and Elena Paschetta declare that theyhave no relevant financial or non-financial interests to disclose,have no conflicts of interest to declare that are relevant to the content of this article,have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript, andhave no financial or proprietary interests in any material discussed in this article.